Xinguang Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A1

  • Investors
  • 7

Xinguang Bio General Information

Description

Manufacturer of biopharmaceutical devices intended for therapeutic and diagnostic application purpose. The company uses enzymes to efficiently, rapidly, and selectively remove harmful molecules from blood, plasma, and dialysis effluents, enabling patients to have an alternative treatment for refractory metabolic diseases, cancer, and liver and kidney malfunction..

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 506, 5th Floor, Building 21, Number 1-28, Lane 588
  • Tianxiong Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 176
Primary Industry
Therapeutic Devices
Corporate Office
  • Room 506, 5th Floor, Building 21, Number 1-28, Lane 588
  • Tianxiong Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 176

Xinguang Bio Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xinguang Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A1) 29-Dec-2025 Completed Generating Revenue
6. Later Stage VC 27-May-2025 Completed Generating Revenue
5. Later Stage VC 08-Aug-2024 Completed Generating Revenue
4. Later Stage VC 22-May-2024 Completed Generating Revenue
3. Early Stage VC 01-Nov-2021 Completed Generating Revenue
2. Early Stage VC 15-May-2021 Completed Generating Revenue
1. Accelerator/Incubator 27-Jun-2019 Completed Startup
To view Xinguang Bio’s complete valuation and funding history, request access »

Xinguang Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xinguang Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xingfu Investment Management Growth/Expansion Minority
Linhui Fund Venture Capital Minority
Shanghai Highpower Industrial Corporation Minority
Empower Investment Venture Capital Minority
Joyin Incubator Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Xinguang Bio FAQs

  • When was Xinguang Bio founded?

    Xinguang Bio was founded in 2018.

  • Where is Xinguang Bio headquartered?

    Xinguang Bio is headquartered in Shanghai, China.

  • What is the size of Xinguang Bio?

    Xinguang Bio has 3 total employees.

  • What industry is Xinguang Bio in?

    Xinguang Bio’s primary industry is Therapeutic Devices.

  • Is Xinguang Bio a private or public company?

    Xinguang Bio is a Private company.

  • What is Xinguang Bio’s current revenue?

    The current revenue for Xinguang Bio is .

  • How much funding has Xinguang Bio raised over time?

    Xinguang Bio has raised $2.94M.

  • Who are Xinguang Bio’s investors?

    Xingfu Investment Management, Linhui Fund, Shanghai Highpower Industrial, Empower Investment, and Joyin Incubator are 5 of 7 investors who have invested in Xinguang Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process